IL6 and COVID-19: Most patients with severe COVID-19 were featured by substantially elevated levels of proinflammatory cytokines, which was characterized as cytokine release syndrome.26–28 Our study also observed abnormally high levels of proinflammatory cytokines (especially IL-6) in some patients prior to CP therapy.